RxDoctor Payments Data

Charbel Chalouhy, MD

Urology · Baltimore, MDNPI 1497157770

Payments from drug & device makers

$6,276in general payments, 2019–2025

Across 61 payments — averaging $102.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axogen$2K
  • Coloplast$1K
  • Kerecis Limited$733
  • Johnson & Johnson$465
  • Boston Scientific$458
  • Teleflex LLC$337
  • plus $1K from 7 others

What the payments were for

  • Food & beverage$6,276100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Axogen16$2,016
Coloplast15$1,122
Kerecis Limited3$733
Johnson & Johnson8$465
Boston Scientific6$458
Teleflex LLC3$337
Davol Inc.2$281
Medtronic3$204
BD1$167
Calyxo, Inc.1$150
Axonics, Inc.1$127
Progenics Pharmaceuticals, Inc.1$124
Rigicon,inc.1$93

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,276 in reported general payments places this provider in the 55th percentile of 274 urology providers in Maryland.

See all urology providers in Maryland

Medicare billing

Part B allowed, 2024
$28,223
Medicare patients
100
Services billed
193

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Solifenacin Succinate148$10,186
Tamsulosin Hcl181$2,827
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst38$945
Finasteride45$680
Alfuzosin Hcl ErAlfuzosin Hcl18$347
Ciprofloxacin Hcl13$167
Levofloxacin17$105

Paid to pharmacies, not to this prescriber.

Other urology in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →